XML 57 R42.htm IDEA: XBRL DOCUMENT v3.23.1

Business Segment Information (Tables)

12 Months Ended

Mar. 31, 2023

Notes To Financial Statements [Abstract]

Schedule of Segment Reporting Information, by Segment

Years Ended March 31,						2023						2022						2021
Revenues:
Healthcare						$	3,085,131					$	2,845,467					$	1,954,055
Applied Sterilization Technologies						914,431						852,972						685,912
Life Sciences						536,704						524,964						467,552
Dental						421,573						361,661						—
Total revenues						$	4,957,839					$	4,585,064					$	3,107,519
Operating income (loss):
Healthcare						706,020						649,704						427,089
Applied Sterilization Technologies						429,020						410,101						310,648
Life Sciences						210,225						216,188						180,796
Dental						89,527						84,441						—
Corporate						(264,791)						(283,665)						(219,153)
Total operating income before adjustments						$	1,170,001					$	1,076,769					$	699,380
Less: Adjustments
Amortization of acquired intangible assets (1)						376,822						366,434						83,892
Acquisition and integration related charges (2)						24,196						205,788						35,634
Tax restructuring costs (3)						661						301						1,592
Gain on fair value adjustment of acquisition related contingent consideration (1)						(3,100)						(2,350)						(500)
Net (gain) loss on divestiture of businesses (1)						(67)						(874)						2,030
Amortization of inventory and property "step up" to fair value (1)						12,254						81,804						5,600
COVID-19 incremental costs (4)						—						—						25,793
Restructuring charges (credit) (5)						485						48						(3,029)
Goodwill impairment loss (6)						490,565						—						—
Total operating income						$	268,185					$	425,618					$	548,368

(1) For more information regarding our recent acquisitions and divestitures, refer to Note 2 titled, "Business Acquisitions and Divestitures."

(2) Acquisition and integration related charges include transaction costs and integration expenses associated with acquisitions.

(3) Costs incurred in tax restructuring.

(4) COVID-19 incremental costs includes the additional costs attributable to COVID-19 such as enhanced cleaning protocols, personal protective equipment for our employees, event cancellation fees, and payroll costs associated with our response to COVID-19, net of any government subsidies available.

(5) For more information regarding our restructuring efforts, refer to our Annual Report on Form 10-K for the year ended March 31, 2021, dated May 28, 2021.

(6) For more information regarding our goodwill impairment loss, refer to Note 3 titled, "Goodwill and Intangible Assets."

March 31,						2023						2022
Assets
Healthcare and Life Sciences						$	6,538,270					$	6,604,893
Applied Sterilization Technologies						3,124,341						3,053,116
Dental						1,159,228						1,765,585
Total assets						$	10,821,839					$	11,423,594

Years Ended March 31,						2023						2022						2021
Capital Expenditures
Healthcare and Life Sciences						$	98,585					$	84,487					$	74,446
Applied Sterilization Technologies						253,914						198,350						164,816
Dental						9,470						4,726						—
Total Capital Expenditures						$	361,969					$	287,563					$	239,262
Depreciation, Depletion, and Amortization (1)
Healthcare and Life Sciences						$	306,377					$	316,222					$	106,266
Applied Sterilization Technologies						116,153						115,925						112,971
Dental						130,367						120,957						—
Total Depreciation, Depletion, and Amortization						$	552,897					$	553,104					$	219,237

(1) Fiscal 2022 totals include approximately $229,052, $35,531 and $113,099 for Healthcare and Life Sciences, Applied Sterilization Technologies, and Dental, respectively, of amortization of acquired intangible assets and amortization of property "step-up" to fair value. For more information regarding our recent acquisitions and divestitures see Note 2 titled, "Business Acquisitions and Divestitures."

Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area

March 31,						2023						2022
Property, Plant, and Equipment, Net
Ireland						$	60,570					$	60,275
United States						946,930						881,057
Other locations						698,012						611,244
Property, Plant, and Equipment, Net						$	1,705,512					$	1,552,576

Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]

Years Ended March 31,						2023						2022						2021
Revenues:
Ireland						$	74,463					$	82,011					$	71,905
United States						3,586,486						3,228,864						2,227,038
Other locations						1,296,890						1,274,189						808,576
Total Revenues						$	4,957,839					$	4,585,064					$	3,107,519

Revenue from External Customers by Products and Services [Table Text Block]

Years Ended March 31,						2023						2022						2021
Healthcare:
Capital equipment						896,590						$	782,505					$	588,864
Consumables						1,050,316						1,004,605						510,946
Service						1,138,225						1,058,357						854,245
Total Healthcare Revenues						$	3,085,131					$	2,845,467					$	1,954,055
Applied Sterilization Technologies:
Capital equipment						$	26,460					$	24,394					$	—
Service						$	887,971					$	828,578					$	685,912
Total Applied Sterilization Technologies Service Revenues						$	914,431					$	852,972					$	685,912
Life Sciences:
Capital equipment						$	147,420					$	142,281					$	128,356
Consumables						241,114						239,365						215,005
Service						148,170						143,318						124,191
Total Life Sciences Revenues						$	536,704					524,964						467,552
Dental Revenues						$	421,573					$	361,661					$	—
Total Revenues						$	4,957,839					$	4,585,064					$	3,107,519

X

- Definition

Notes to Financial Statements [Abstract]

+ References

No definition available.

+ Details

Name:	ste_NotesToFinancialStatementsAbstract
Namespace Prefix:	ste_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Subparagraph a
-SubTopic 10
-Topic 280
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-41

+ Details

Name:	us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-40

+ Details

Name:	us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-41

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2

+ Details

Name:	us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482573/350-20-50-1

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-25

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-22

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration